New strain emerges from world’s longest case of COVID-19 The treatment-resistant variant mutated after infecting a heavily immunosuppressed man for 613 days but was not passed on to the community.
Antipsychotics for dementia raise ‘risk of serious harm’: Study From pneumonia to heart attacks, new research revealed the drugs do more harm than first thought, with the risks highest soon after initiation.
Study shows long COVID symptoms resolve for most But research is needed to understand what can be done for the one in three people with ongoing symptoms after two years.
Modelling reveals number of lives saved by COVID vaccine rollout Research suggests the campaign saved nearly 18,000 over-50s in NSW alone between August 2021 and July 2022.
Study questions Paxlovid’s COVID-19 ‘usefulness’ Researchers say the antiviral does little to reduce symptom duration for some vaccinated patients, but still recommended its use for the vulnerable.
Long COVID diagnosis ‘validation’ for suffering patients A GP expert is speaking out after Queensland’s CHO said the term ‘long COVID’ can cause ‘unnecessary fear’ and should be scrapped.
In Practice: Long COVID support for GPs The RACGP is hosting a CPD-approved session to keep GPs up to date with effective diagnosis and management for often complex long COVID conditions.
How COVID-19 leaves its mark on the brain Mounting research shows the disease can lead to an array of problems, including significant drops in IQ scores, writes Dr Ziyad Al-Aly.
Rapidly changing evidence sparks need for ‘living’ guidelines The RACGP has requested Federal Government support to establish clinical resources that incorporate new information as it comes to hand.
Why the emergence of JN.1 is significant The new COVID variant is an evolutionary ‘step change’ in the pandemic, according to Australian researchers.